BridgeMD
New treatment option for Chronic Subdural Hematoma
Official title Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence
ClinicalTrials.gov ID: NCT06911736
What this study is testing
- What it's testing
- Objective: Determine the effect of the postoperative trendelenburg position on the recurrence of chronic subdural hematoma (CSH) in patients undergoing surgery. Materials and Methods: An open-label, randomized, controlled clinical trial was conducted in three hospitals in Medellín.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The study included patients aged 18 years or older who required surgical management of symptomatic CSH confirmed by CT scan and whose informed...
You likely can't join if
- Pregnant or breastfeeding
- Conditions in which the trendelenburg position might not be safe, such as intracranial hypertension without a drain to allow evacuation of the...
- History of ipsilateral chronic subdural hematoma drainage, intracranial hypotension syndrome, ventriculoperitoneal shunting
- Simultaneous participation in any other clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Medellín, Antioquia, Colombia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Medellín, Antioquia, Colombia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.